Autres langues Cessatech A/S

Actions

CESSA

DK0061411964

Cours en clôture NORDIC GROWTH MARKET 28/08/2026			Varia. 5j.	Varia. 1 janv.
11,15 ^DKK	+20,93%		+14,95%	-30,14%

28/08	Cessatech A/S publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
28/08	Cessatech rapporte une perte d'exploitation en légère diminution	FW

Autres langues

28/08	Cessatech A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
28/08	Second Quarter Report Q2-2026
27/08	CT001 ready for shipment to initial U.S. hospitals as launch activities commence
27/08	Cessatech Releases CT001 For Shipment To Initial U.S. Hospitals And Commences Launch Activities
03/08	Cessatech: Cessatech – EMA initial KemSu/CT001 opinion Q&A and next steps
03/08	Cessatech - EMA initial KemSu/CT001 opinion Q&A and next steps
24/07	Cessatech: Proveca intends to request a re-examination of CHMP opinion for CT001/KemSu
24/07	Proveca intends to request a re-examination of CHMP opinion for CT001/KemSu
12/06	Cessatech enters collaboration with University Hospital of Copenhagen, Rigshospitalet, to advance an intravenous formulation of melatonin for post-anaesthesia delirium (CT004) in children
12/06	Cessatech A/S and University Hospital of Copenhagen, Rigshospitalet Enter Collaboration to Advance Intravenous Formulation of Melatonin for Post-Anaesthesia Delirium in Children
28/05	First Quarter Report Q1-2026
28/05	Cessatech A/S Reports Earnings Results for the First Quarter Ended March 31, 2026
30/03	Minutes from the Annual General Meeting in Cessatech A/S
13/03	Cessatech convenes its Annual General Meeting
27/02	Cessatech A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
27/02	Cessatech A/S Announces Financial Results for the Full Year 2025
27/02	Cessatech A/S Auditor Raises 'Going Concern' Doubt
02/02	Welcome to the first quarter of 2026
13/11	Cessatech A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
13/11	Cessatech: Third Quarter Report Q3-2025
13/11	Third Quarter Report Q3-2025
31/10/25	Cessatech: CT001 soon available for US hospitals in collaboration with STAQ Pharma, for acute pain management in children
31/10/25	CT001 soon available for US hospitals in collaboration with STAQ Pharma, for acute pain management in children
21/08/25	Cessatech A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
21/08/25	Cessatech: Second Quarter Report Q2-2025